Researcher profile

Raphaël Porcher

Raphaël Porcher contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2026arXiv

Choosing Covariate Balancing Methods for Causal Inference: Practical Insights from a Simulation Study

Background: Inverse probability of treatment weighting (IPTW) is used for confounding adjustment in observational studies. Newer weighting methods include energy balancing (EB), kernel optimal matching (KOM), and tailored-loss covariate balancing propensity scores (TLF), but practical guidance remains limited. We evaluate their performance when implemented according to published recommendations. Methods: We conducted Monte Carlo simulations across 36 scenarios varying sample size, treatment prevalence, and a complexity factor increasing confounding and reducing overlap. Data generation used predominantly categorical covariates with some correlation. Average treatment effect and average treatment effect on the treated were estimated using IPTW, EB, KOM, and TLF combined with weighted least squares and, when supported, a doubly robust (DR) estimators. Inference followed published recommendations for each method when feasible, using standard alternatives otherwise. \textsc{PROBITsim} dataset used for illustration. Results: DR reduced sensitivity to the weighting scheme with an outcome regression adjusted for all confounders, despite functional-form misspecification. EB and KOM were most reliable; EB was tuning-free but scale dependent, whereas KOM required kernel and penalty choices. IPTW was variance sensitive when treatment prevalence was far from 50\%. TLF traded lower variance for higher bias, producing an RMSE plateau and sub-nominal confidence interval coverage. \textsc{PROBITsim} results mirrored these patterns. Conclusions: Rather than identifying a best method, our findings highlight failure modes and tuning choices to monitor. When the outcome regression adjusts for all confounders, DR estimation can be dependable across weighting schemes. Incorporating weight-estimation uncertainty into confidence intervals remains a key challenge for newer approaches.

preprint2022arXiv

How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?

PURPOSE Providing rapid answers and early acces to patients to innovative treatments without randomized clinical trial (RCT) is growing, with benefit estimated from single-arm trials. This has become common in oncology, impacting the approval pathway of health technology assessment agencies. We aimed to provide some guidance for indirect comparison to external controls to improve the level of evidence following such uncontrolled designs. METHODS We used the illustrative example of blinatumomab, a bispecific antibody for the treatment of B-cell ALL in complete remission (CR) with persistent minimal residual disease (MRD). Its approval relied on a single-arm trial conducted in 86 adults with B-cell ALL in CR, with undetectable MRD after one cycle as the main endpoint. To maximize the validity of indirect comparisons, a 3-step process for incorporating external control data to such single-arm trial data is proposed and detailed, with emphasis on the example. RESULTS The first step includes the definition of estimand, i.e. the treatment effect reflecting the clinical question. The second step relies on the adequate selection of external controls, from previous RCT or real-world data (RWD) obtained from patient cohort, registries, or electronic patient files. The third step consists in chosing the statistical approach targeting the treatment effect of interest, either in the whole population or restricted to the single-arm trial or the external controls, and depending on the available individual-level or aggregrated external data. CONCLUSION Validity of treatment effect derived from indirect comparisons heavily depends on carefull methodological considerations that are included in the proposed 3-step procedure. Because the level of evidence of a well conducted RCT cannot be guaranteed, post-market authorization evaluation is even more important than in standard settings.

preprint2021arXiv

Wasserstein Random Forests and Applications in Heterogeneous Treatment Effects

We present new insights into causal inference in the context of Heterogeneous Treatment Effects by proposing natural variants of Random Forests to estimate the key conditional distributions. To achieve this, we recast Breiman's original splitting criterion in terms of Wasserstein distances between empirical measures. This reformulation indicates that Random Forests are well adapted to estimate conditional distributions and provides a natural extension of the algorithm to multivariate outputs. Following the philosophy of Breiman's construction, we propose some variants of the splitting rule that are well-suited to the conditional distribution estimation problem. Some preliminary theoretical connections are established along with various numerical experiments, which show how our approach may help to conduct more transparent causal inference in complex situations.